US Patent Issued to Princeton Biochemicals on Sept. 16 for "Method and system for exposing hidden or masked antigenic sites of viral specimens present in biosamples using a home-based COVID-19 rapid lateral flow immunoassay test" (New Jersey Inventor)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,416,633, issued on Sept. 16, was assigned to Princeton Biochemicals (Princeton, N.J.).

"Method and system for exposing hidden or masked antigenic sites of viral specimens present in biosamples using a home-based COVID-19 rapid lateral flow immunoassay test" was invented by Norberto A. Guzman (East Brunswick, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A disease detection system including a platform or cartridge to perform testing using a rapid lateral flow chromatographic immunoassay (LFIA) test intended for the qualitative detection of the disease in a sample, such as collected sputum, disrupted by a digestive enzyme and a detergent to release...